Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan Masataka SawakiAkimitsu YamadaShigehira Saji Special Article 21 November 2020 Pages: 1 - 8
Axillary surgery for breast cancer: past, present, and future Masakuni NoguchiMasafumi InokuchiTomoko Kurita Review Article 09 November 2020 Pages: 9 - 15
Resistance training in breast cancer patients undergoing primary treatment: a systematic review and meta-regression of exercise dosage Pedro LopezDaniel A. GalvãoRonei S. Pinto Review Article 19 August 2020 Pages: 16 - 24
Obesity-related protein biomarkers for predicting breast cancer risk: an overview of systematic reviews Xueyao WuXiaofan ZhangJiayuan Li Review Article 25 November 2020 Pages: 25 - 39
Effect of adjuvant chemotherapy in patients with ER + /HER2− breast cancer, assessed by propensity score matching: significance of nuclear grade and nodal status Natsuko TanakaAkira HiranoTadao Shimizu Original Article 26 June 2020 Pages: 40 - 47
Sedentary behavior and risk of breast cancer: a dose–response meta-analysis from prospective studies Feifei ChongYanli WangChunhua Song Original Article 30 June 2020 Pages: 48 - 59
In vitro anti-breast cancer studies of LED red light therapy through autophagy Kok Lee YangBoon Yin KhooSubramaniam Sreeramanan Original Article 11 July 2020 Pages: 60 - 66
The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer Wakako TajiriHideki IjichiEriko Tokunaga Original Article Open access 29 June 2020 Pages: 67 - 74
Investigation of the significance of population-based breast cancer screening among women aged under 40 years Mai OkazakiHiroko BandoHisato Hara Original Article 08 July 2020 Pages: 75 - 81
Triple-negative breast cancer incidence in the United States: ecological correlations with area-level sociodemographics, healthcare, and health behaviors Jennifer L. MossZaria TatalovichKathleen A. Cronin Original Article 15 July 2020 Pages: 82 - 91
Ipsilateral breast tumor control following hypofractionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow-up Yuko Yoshida-IchikawaYoshiya HorimotoKumiko Karasawa Original Article 27 July 2020 Pages: 92 - 98
Pathophysiology of neratinib-induced diarrhea in male and female rats: microbial alterations a potential determinant Kate R. SecombeImogen A. BallJoanne M. Bowen Original Article 18 July 2020 Pages: 99 - 109
The role of adjuvant radiotherapy in patients with malignant phyllodes tumor of the breast: a propensity-score matching analysis Wen ZhaoQi TianJin Yang Original Article Open access 03 August 2020 Pages: 110 - 118
Detection of breast cancer precursor lesions by autofluorescence ductoscopy Laurien WaaijerMando D. FilipeArjen Joost Witkamp Original Article Open access 28 July 2020 Pages: 119 - 129
Mapping the cancer-specific FACT-B onto the generic SF-6Dv2 Azin NahvijouHossein SafariHosein Ameri Original Article 25 July 2020 Pages: 130 - 136
Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency Gianluca VanniMarco PellicciaroOreste Claudio Buonomo Original Article Open access 30 July 2020 Pages: 137 - 144
Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study Yutaka YamamotoHiroyasu YamashiroShinji Ohno Original Article Open access 26 July 2020 Pages: 145 - 160
A survey on the current status of clinical resources for diagnosis and treatment of breast cancer in rural hospitals of the Tohoku region in Japan Kazushige IshidaKoji OhnukiAkira Sasaki Original Article 13 August 2020 Pages: 161 - 167
Fibromatosis of the breast: a 10-year multi-institutional experience and review of the literature Michael R. BolandTimothy NugentElizabeth M. Connolly Original Article 11 August 2020 Pages: 168 - 174
miR-484 suppresses endocrine therapy-resistant cells by inhibiting KLF4-induced cancer stem cells in estrogen receptor-positive cancers Yulei WeiHong LiQuanxin Qu Original Article 31 August 2020 Pages: 175 - 186
The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast Hengqiang Zhao Original Article 18 August 2020 Pages: 187 - 195
Patient and clinician satisfaction and clinical outcomes of Magseed compared with wire-guided localisation for impalpable breast lesions Aikaterini E. MichaVictoria SinnettJennifer E. Rusby Original Article Open access 24 September 2020 Pages: 196 - 205
Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells Ryohei OgataEmi KishinoJunichi Kurebayashi Original Article Open access 28 August 2020 Pages: 206 - 215
Development and biological assessment of MMAE-trastuzumab antibody–drug conjugates (ADCs) Sajad YaghoubiTohid GharibiMeghdad Abdollahpour-Alitappeh Original Article 05 September 2020 Pages: 216 - 225
Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population Emilia Rogoża-JaniszewskaKarolina MalińskaTadeusz Dębniak Original Article Open access 04 September 2020 Pages: 226 - 235
Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms Yen-Hsuan HsuVincent Chin-Hung ChenMichael Gossop Original Article 08 October 2020 Pages: 236 - 245
Correction to: Atypical ductal hyperplasia and the risk of underestimation: tissue sampling method, multifocality, and associated calcification significantly influence the diagnostic upgrade rate based on subsequent surgical specimens Christoph J. RagethRavit RubenovZsuzsanna Varga Correction 25 November 2020 Pages: 246 - 246